Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (501-510 of 13,981) with videos related to

Pageof 1,399
Sort By:
Leukemia|February 24, 2001
Kinases: positive and negative regulators of apoptosisR A Franklin, J A McCubrey
Leukemia|February 24, 2001
A transient dephosphorylation of JAK1 and JAK2 characterises the early-phase response of murine erythroleukemia cells to the differentiation inducer hexamethylenebisacetamideA Arcangeli, L Fontana, O Crociani, et al.
Leukemia|February 24, 2001
Human mortalin (HSPA9): a candidate for the myeloid leukemia tumor suppressor gene on 5q31H Xie, Z Hu, B Chyna, et al.
Leukemia|February 24, 2001
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995V Conter, M Aricò, M G Valsecchi, et al.
Leukemia|February 24, 2001
Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991W A Kamps, A J Veerman, E R van Wering, et al.
Leukemia|February 24, 2001
Intrathecal mitozantrone has to be prohibitedJ H Dalle, A Lambilliotte, A S Defachelles, et al.
Leukemia|March 10, 2001
Detection of minimal residual disease in acute lymphoblastic leukemia: the St Jude experienceD Campana, G A Neale, E Coustan-Smith, et al.
Leukemia|March 10, 2001
Treatment response and residual-disease monitoring in initial and relapsed TEL-AML1 positive childhood ALLK Seeger, S Viehmann, D Buchwald, et al.
Leukemia|March 10, 2001
Rapid isolation of chromosomal breakpoints from patients with t(4;11) acute lymphoblastic leukemia: implications for basic and clinical researchM Reichel, E Gillert, I Breitenlohner, et al.
Leukemia|March 10, 2001
Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSFG Jahns-Streubel, J Braess, C Schoch, et al.
Pageof 1,399

Showing results (501-510 of 13,981) with videos related to

Sort By:
Pageof 1,399
Leukemia|February 24, 2001
Kinases: positive and negative regulators of apoptosisR A Franklin, J A McCubrey
Leukemia|February 24, 2001
A transient dephosphorylation of JAK1 and JAK2 characterises the early-phase response of murine erythroleukemia cells to the differentiation inducer hexamethylenebisacetamideA Arcangeli, L Fontana, O Crociani, et al.
Leukemia|February 24, 2001
Human mortalin (HSPA9): a candidate for the myeloid leukemia tumor suppressor gene on 5q31H Xie, Z Hu, B Chyna, et al.
Leukemia|February 24, 2001
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995V Conter, M Aricò, M G Valsecchi, et al.
Leukemia|February 24, 2001
Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991W A Kamps, A J Veerman, E R van Wering, et al.
Leukemia|February 24, 2001
Intrathecal mitozantrone has to be prohibitedJ H Dalle, A Lambilliotte, A S Defachelles, et al.
Leukemia|March 10, 2001
Detection of minimal residual disease in acute lymphoblastic leukemia: the St Jude experienceD Campana, G A Neale, E Coustan-Smith, et al.
Leukemia|March 10, 2001
Treatment response and residual-disease monitoring in initial and relapsed TEL-AML1 positive childhood ALLK Seeger, S Viehmann, D Buchwald, et al.
Leukemia|March 10, 2001
Rapid isolation of chromosomal breakpoints from patients with t(4;11) acute lymphoblastic leukemia: implications for basic and clinical researchM Reichel, E Gillert, I Breitenlohner, et al.
Leukemia|March 10, 2001
Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSFG Jahns-Streubel, J Braess, C Schoch, et al.
Pageof 1,399